These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 31123247

  • 1. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA, Reinhart V, Sheehan MJ, Rizzo SJS, Bove SE, James LC, Volfson D, Lewis DA, Kleiman RJ.
    Transl Psychiatry; 2019 May 23; 9(1):151. PubMed ID: 31123247
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
    Reinhart V, Bove SE, Volfson D, Lewis DA, Kleiman RJ, Lanz TA.
    Neurobiol Dis; 2015 May 23; 77():220-7. PubMed ID: 25796564
    [Abstract] [Full Text] [Related]

  • 3. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K, Carvalho LA, Drexhage RC, Wijkhuijs A, de Wit H, van Beveren NJ, Birkenhäger TK, Bergink V, Drexhage HA.
    Brain Behav Immun; 2011 Aug 23; 25(6):1162-9. PubMed ID: 21421043
    [Abstract] [Full Text] [Related]

  • 4. Altered DLPFC-Hippocampus Connectivity During Working Memory: Independent Replication and Disorder Specificity of a Putative Genetic Risk Phenotype for Schizophrenia.
    Schneider M, Walter H, Moessnang C, Schäfer A, Erk S, Mohnke S, Romund L, Garbusow M, Dixson L, Heinz A, Romanczuk-Seiferth N, Meyer-Lindenberg A, Tost H.
    Schizophr Bull; 2017 Sep 01; 43(5):1114-1122. PubMed ID: 28207073
    [Abstract] [Full Text] [Related]

  • 5. Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.
    Kaalund SS, Newburn EN, Ye T, Tao R, Li C, Deep-Soboslay A, Herman MM, Hyde TM, Weinberger DR, Lipska BK, Kleinman JE.
    Mol Psychiatry; 2014 Dec 01; 19(12):1258-66. PubMed ID: 24322206
    [Abstract] [Full Text] [Related]

  • 6. Brain Inflammatory Marker Abnormalities in Major Psychiatric Diseases: a Systematic Review of Postmortem Brain Studies.
    Ai YW, Du Y, Chen L, Liu SH, Liu QS, Cheng Y.
    Mol Neurobiol; 2023 Apr 01; 60(4):2116-2134. PubMed ID: 36600081
    [Abstract] [Full Text] [Related]

  • 7. Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder.
    Ho AM, Winham SJ, Armasu SM, Blacker CJ, Millischer V, Lavebratt C, Overholser JC, Jurjus GJ, Dieter L, Mahajan G, Rajkowska G, Vallender EJ, Stockmeier CA, Robertson KD, Frye MA, Choi DS, Veldic M.
    J Psychiatr Res; 2019 Oct 01; 117():45-54. PubMed ID: 31279243
    [Abstract] [Full Text] [Related]

  • 8. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
    Yin B, Cai Y, Teng T, Wang X, Liu X, Li X, Wang J, Wu H, He Y, Ren F, Kou T, Zhu ZJ, Zhou X.
    Transl Psychiatry; 2024 Mar 26; 14(1):163. PubMed ID: 38531835
    [Abstract] [Full Text] [Related]

  • 9. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G, Delvecchio G, Sambataro F, Brambilla P.
    J Affect Disord; 2022 Aug 01; 310():213-222. PubMed ID: 35533776
    [Abstract] [Full Text] [Related]

  • 10. Post-mortem molecular profiling of three psychiatric disorders.
    Ramaker RC, Bowling KM, Lasseigne BN, Hagenauer MH, Hardigan AA, Davis NS, Gertz J, Cartagena PM, Walsh DM, Vawter MP, Jones EG, Schatzberg AF, Barchas JD, Watson SJ, Bunney BG, Akil H, Bunney WE, Li JZ, Cooper SJ, Myers RM.
    Genome Med; 2017 Jul 28; 9(1):72. PubMed ID: 28754123
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
    Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT.
    Int J Neuropsychopharmacol; 2011 Feb 28; 14(1):123-30. PubMed ID: 20633320
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
    Perlman WR, Tomaskovic-Crook E, Montague DM, Webster MJ, Rubinow DR, Kleinman JE, Weickert CS.
    Biol Psychiatry; 2005 Nov 15; 58(10):812-24. PubMed ID: 16112656
    [Abstract] [Full Text] [Related]

  • 17. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
    Kunii Y, Hyde TM, Ye T, Li C, Kolachana B, Dickinson D, Weinberger DR, Kleinman JE, Lipska BK.
    Mol Psychiatry; 2014 Feb 15; 19(2):192-9. PubMed ID: 23295814
    [Abstract] [Full Text] [Related]

  • 18. Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings.
    Marballi K, Cruz D, Thompson P, Walss-Bass C.
    PLoS One; 2012 Feb 15; 7(5):e36431. PubMed ID: 22590542
    [Abstract] [Full Text] [Related]

  • 19. Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study.
    Odagaki Y, Kinoshita M, Meana JJ, Callado LF, García-Sevilla JA.
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct 15; 270(7):869-880. PubMed ID: 31807862
    [Abstract] [Full Text] [Related]

  • 20. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
    Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, Shimasaki A, Kawase K, Sakusabe T, Iwayama Y, Toyota T, Wakuda T, Kikuchi M, Kanahara N, Yamamori H, Yasuda Y, Watanabe Y, Hoya S, Aleksic B, Kushima I, Arai H, Takaki M, Hattori K, Kunugi H, Okahisa Y, Ohnuma T, Ozaki N, Someya T, Hashimoto R, Yoshikawa T, Kubo M, Iwata N.
    Schizophr Bull; 2019 Jun 18; 45(4):824-834. PubMed ID: 30285260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.